Deloitte Consulting Services has acquired Recombinant Data, a developer of data warehousing and clinical intelligence systems for personalized medicine, translational research and healthcare performance management. Terms of the acquisition were not disclosed.

Based in Newton, Mass., Recombinant, founded in 2005, seeks to relate to enterprise data integration, population health analytics, clinical genome data assimilation and performance management for accountable care organizations. According to Deloitte, Recombinant also seeks to assist academic medical centers, federal agencies and life sciences companies conduct translational research and analyze phenomic, genomic and bio-banking data in pursing personalized and evidence-based medicine.

Recombinant’s business will reside within Deloitte Consulting Innovation under the name “Recombinant By Deloitte.”